Question special
Lead Moderator

Thanks everyone for the lively discussion so far and to Dr. Pollack for his detail responses to all the questions!

The paper mentioned two categories where reversal of dabigatran was indicated - major bleeding or the need for reversal before emergent surgery. Are there any other indications that were considered? If so, what are they and is there any plan for further testing for those indications?